Neuronal specific enolase 2 (ENO2) has been studied as a biomarker in the progression of multiple sclerosis. It converts 2-phosphoglycerate into phosphoenolpyruvate.
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Neuronal specific enolase 2 (ENO2) is also known as ?-enolase. It is present in the cytoplasm of neuroendocrine cells.
brain NSE from human.
Prediluted in 20 mM HEPES, containing 135 mM NaCI, 1% BSA, and 0.09% sodium azide.